Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping Meeting Abstract


Authors: Kato, T.; Yang, J. C. H.; Ahn, M. J.; Sakai, H.; Morise, M.; Chen, Y. M.; Han, J. Y.; Yang, J. J.; Zhao, J.; Huang, J.; Berghoff, K.; Bruns, R.; Vioix, H.; Otto, G.; Le, X.; Paik, P. K.
Abstract Title: Tepotinib in Asian patients with advanced NSCLC with MET exon 14 (METex14) skipping
Meeting Title: 2022 ASCO Annual Meeting
Journal Title: Journal of Clinical Oncology
Volume: 40
Issue: 16 Suppl.
Meeting Dates: 2022 Jun 3-7
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2022-06-01
Language: English
ACCESSION: WOS:000863680302305
PROVIDER: wos
DOI: 10.1200/JCO.2022.40.16_suppl.9120
Notes: Meeting Abstract: 9120 -- Meeting also held virtually -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Paul K Paik
    256 Paik